Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 03, 2025

Get In Touch

MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB Patients Pharma News

MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB Patients

  • 02 November 2025
  • 1 day ago

Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet Pharma News

Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet

  • 14 October 2025
  • 2 weeks ago

CDSCO Panel Approves Novo Medi Sciences' Phase III Booster Study of PCV13 Pneumococcal Vaccine in Infants Pharma News

CDSCO Panel Approves Novo Medi Sciences' Phase III Booster Study of PCV13 Pneumococcal Vaccine in Infants

  • 27 September 2025
  • 1 month ago

CDSCO Panel Asks Akums for Detailed Data on Phase III Eye Drop Trial Pharma News

CDSCO Panel Asks Akums for Detailed Data on Phase III Eye Drop Trial

  • 23 September 2025
  • 1 month ago

CDSCO Panel Asks Wockhardt to Revise Phase III Study Protocol for Nafithromycin, Seeks Dosing, Control Arm Changes Pharma News

CDSCO Panel Asks Wockhardt to Revise Phase III Study Protocol for Nafithromycin, Seeks Dosing, Control Arm Changes

  • 16 September 2025
  • 1 month ago

Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus' Phase III CT Waiver Request for Voclosporin Pharma News

Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus' Phase III CT Waiver Request for Voclosporin

  • 13 September 2025
  • 1 month ago

Ultra Rapid Lispro In Basal-Bolus Regimen Bests Lispro For PPG Control In Type 2 Diabetes Diabetes and Endocrinology

Ultra Rapid Lispro In Basal-Bolus Regimen Bests Lispro For PPG Control In Type 2 Diabetes

  • 04 August 2025
  • 2 months ago

Recent News

Nanotechnology Reverses Alzheimer's Symptoms in Mi...

  • 03 November, 2025

Gum disease could silently cause serious brain dam...

  • 03 November, 2025

Can Early-Day Fasting Significantly Boost Metaboli...

  • 03 November, 2025

Delhi HC bars doctor from running medical centre d...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.